News | January 15, 2009

RT Delayed too Long after Breast Surgery Adversely Affects Outcomes

January 15, 2009 - There is no survival disadvantage to waiting up to 20 weeks to start radiation therapy (RT) after breast-conserving surgery (BCS), but delaying more than that does adversely affect outcomes, according to results from a large study published in the January 2009 issue of Journal of Clinical Oncology (J Clin Oncol, 2009 Jan 1, IA Olivotto, et al).

"To date, the optimal, maximally acceptable delay time to begin RT after BCS has not been clearly defined," noted Lee Schwartzberg, M.D., Ph.D., editor-in-chief of OncologySTAT.

Dr. Schwartzberg noted that "[t]his prospectively evaluated, large, population-based study from British Columbia determined that initiation of external-beam RT up to 20 weeks after BCS, in the absence of adjuvant chemotherapy, was associated with similar outcome to earlier initiation. Delay beyond 5 months significantly compromised both the local-regional failure rate (10 percent vs 5.6 percent) and breast cancer–specific survival.

He added, "Left unanswered is how the interspersion of adjuvant systemic chemotherapy, typically given after BCS and before RT, would affect these results."

For more information: www.oncologystat.com

Related Content

RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
Overlay Init